Global Hemostats Market is projected to witness a decent growth of 6% by 2026 - Growth in Surgical Procedures, Rising Cases of Trauma & Shrinking Blood Supply/Donor Pool in many Countries

Hemostasis is the body's natural reaction to an injury which stops the bleeding and repairs the damage done. The capability helps in conserving blood and prevents any further infection. Hemostats are surgical tools which are used in surgical procedures to control any further bleeding.

Technological Advancements in Healthcare are driving the Growth of the Global Hemostats Market

Uncontrollable and unstoppable bleeding poses many fatality risks and costs in the battlefield, emergency, and hospital settings. To address these concerns, all top players operating in the hemostats market are focusing on developing hemostatic agents that can quickly control bleeding, possess antibacterial properties, and can be used as adjuncts to control bleeding during surgical procedures, and control residual problematic bleeding if conventional methods fails.

Plastic Surgery - An Untapped and Open Market

Plastic surgery represents a significant opportunity for the growth of the hemostats market. Similar to most surgical procedures, plastic surgery procedures are also associated with many complications. Seromas and hematomas are mostly common complications associated with plastic surgery procedures. These complications severely impact the wound healing and result in substantial morbidity in patients. The use of hemostatic agents can reduce these complications, achieve immediate hemostasis for the local bleeding site, allow earlier drain removal, and potentially avoid the use of drains altogether.

"Technologically advanced products are likely to be more successful in the hemostats market. I think, there is only one product in the global market which has complementary characteristics of advanced bleeding control and antimicrobial activity." - Director, Leading Hemostat Manufacturer, United States

Emerging Markets Poised to Drive the Hemostatic Agents Market

Emerging markets such as China, India, and South Korea are estimated to witness double-digit growth in the upcoming years. The consistent and rapid growth in the emerging markets is likely to be driven by lower-priced hemostatic products that are largely commoditized. The huge volume of surgical procedures, growing cases of trauma injuries, rising cases of organ transplantation, foray of local market players, and growing capabilities of surgeons to undertake more complex and technically-challenging procedures that require efficacious, fast-acting hemostats to control bleeding are some of the primary factors which are expected to fuel the demand of hemostatic agents in the emerging markets.

Reliable Growth Strategies Adopted by Leading Market Players to Establish Their Strong Foothold in Hemostats Market

The global hemostats market is marked by the presence of both established and emerging industry players. Players operating in this global market have adopted both organic and inorganic growth strategies such as new product launches, collaborations and acquisitions to garner a higher market share.

The global hemostats market is projected to continue its growth due to the growth in surgical procedure volumes, technological advancements in hemostats, increasing usage of hemostats in military, emergency medical services (EMS) & hospitals, and commercial opportunities in minimally invasive surgery (MIS), plastic surgery, and knee replacement surgery.

Competitive Landscape Analysis: Global Hemostats Market

The global hemostats market is marked by the presence of established market players such as Baxter, Ethicon, B. Braun, Becton Dickinson, Pfizer, CryoLife, Teleflex (Z-Medica), Integra LifeSciences, Biomup, Medtronic, etc.

Get Detailed Insights on Hemostats Market with a Sample Report PDF @ https://meditechinsights.com/hemostats-market/

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

This release was published on openPR.